The present invention relates to the field of DNA recombinant technology. More
specifically, this invention relates to fusion proteins comprising an ATP generating
polypeptide joined to a polypeptide that converts ATP into a detectable entity.
Accordingly, this invention focuses on sulfurylase-luciferase fusion proteins.
This invention also relates to pharmaceutical compositions containing the fusion
proteins and methods for using them.
